{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fproactive-interviews-for-investors.simplecast.com%2Fepisodes%2F20260820-marimed-inc-oCV7esna","width":444,"version":"1.0","type":"rich","title":"MariMed delivers record revenue quarter as branded strategy gains momentum","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/92f9cc71-7d4c-4ec0-a2f3-6a6b31027b4c/3fd3b604-35cf-4701-acde-0f1fdf33d67a/square-with-type.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"","height":200,"description":"MariMed CEO Jon Levine joined Steve Darling from Proactive to discuss the company's strongest financial quarter to date, highlighting record revenue growth, improving margins and continued expansion of its branded cannabis portfolio.\n\nLevine said the company's latest quarter marked a record for revenue, driven by strength across both its retail and wholesale businesses. He noted that investments in operational systems, brand development and market expansion are now beginning to generate meaningful results, contributing to both top-line growth and improved profitability.\n\nMariMed operates as a multi-state, seed-to-sale cannabis company, with fully vertical operations in Massachusetts, Delaware, Maryland and Illinois, as well as a retail presence in Ohio. Levine said the company's leading brands, including Betty's Eddies and Calm Fusion, currently hold the top market position in each state where they compete.\n\nA key component of MariMed's growth strategy is continuous brand innovation. Levine explained that the company regularly introduces seasonal and limited-edition products, such as holiday-themed and summer-inspired edible offerings, to keep brands relevant, encourage repeat purchases and strengthen customer loyalty. Expanding the reach of existing brands, including into new product categories such as flower, remains a major focus for future growth.\n\nLooking at the broader U.S. cannabis industry, Levine said the market continues to be governed largely on a state-by-state basis, with limited federal progress to date. However, he remains optimistic that potential federal cannabis rescheduling could simplify operations, reduce regulatory burdens and attract additional institutional and retail investors to the sector.\n\nLevine added that many investors believe MariMed's stock valuation does not fully reflect its financial performance and operational progress. He believes greater regulatory clarity and broader acceptance of cannabis as an investment category could help close that gap over time\n\n#proactiveinvestors #marimed #cse #mrmd #otcqb #mrmd #jonlevine #Cannabis #CannabisStocks #CannabisIndustry #USCannabis #CannabisInvesting #Edibles #CannabisBrands #CannabisMarket #Proactive\n"}